• The New York Times , Friday, September 19, 2008 10:45 AM

The Supreme Court will hear a labeling case this November that will have implications for all drug marketers, the Times reports in a front page story. The issue boils down to whether warning labels set by federal regulatory agencies constitute a floor, or a ceiling, for state regulation.

The case involves a woman in Vermont who lost part of her arm to gangrene after taking a drug to prevent nausea from another medication. She has argued successfully in Vermont Supreme Court that the warning label did not adequately spell out the risks for a certain type of injection.

The Times story leads and concludes with the empathetic fact that the woman, Diana Levine, played bass professionally in rock and roll bands and is now reduced to playing air guitar with her stump.

Read the whole story at The New York Times »